CAR

Avis Budget Group, Inc.
$101.86
+0.52 (+0.51%)
Mkt Cap 3.60B
Volume 424,349
52W Range 85.96-847.7
Sector Industrials
Beta 1.90
EPS (TTM) -18.03 USD
P/E Ratio -5.08
Revenue (TTM) 11.71B USD
Rev Growth (5Y) +16.6%
EPS Growth (5Y) N/A
AlphaVal · Fair Value
What we estimate one share is worth
$417.26
Undervalued strong signal
75.6% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Stable Earnings Power
30.0 / 100 pillar composite (overridden)
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 11.65B 11.79B 12.01B 11.99B 9.31B 5.40B 9.17B 9.12B 8.85B 8.66B 8.50B 8.48B
Net Income (889.00M) (1.82B) 1.63B 2.76B 1.28B (684.00M) 302.00M 165.00M 361.00M 163.00M 313.00M 245.00M
EPS -25.26 -51.23 42.61 58.44 19.80 -9.70 4.02 2.08 4.32 1.78 3.02 2.32
Free Cash Flow (11.98B) (6.54B) (11.63B) 576.00M (2.59B) 3.95B (91.00M) (563.00M) 513.00M 482.00M 137.00M 188.00M
FCF / Share -340.28 -184.34 -303.66 12.18 -39.97 56.01 -1.21 -7.10 6.15 5.24 1.32 1.78
Operating CF 3.30B 3.52B 3.83B 4.71B 3.49B 691.00M 2.59B 2.61B 2.65B 2.63B 2.58B 2.58B
Total Assets 32.19B 29.95B 33.42B 25.93B 22.60B 17.54B 23.93B 19.23B 17.84B 17.79B 17.85B 17.02B
Total Debt 31.17B 26.04B 26.45B 20.92B 17.80B 13.66B 17.12B 13.78B 12.82B 12.40B 12.32B 11.54B
Cash & Equiv 519.00M 537.00M 559.00M 572.00M 537.00M 693.00M 689.00M 620.00M 618.00M 490.00M 452.00M 624.00M
Book Value (3.13B) (2.33B) (349.00M) (703.00M) (220.00M) (155.00M) 656.00M 414.00M 573.00M 221.00M 439.00M 665.00M
Return on Equity N/A N/A N/A N/A N/A N/A 0.46 0.40 0.63 0.74 0.71 0.37
CAR News
Anixa Biosciences Announces Completion of Treatment of Fifth Cohort in its Ovarian Cancer CAR-T Clinical Trial
Oct 26, 2026 04:30 AM · prnewswire.com
TG Therapeutics Announces Phase 1 Data Evaluating Azer-cel in Progressive Multiple Sclerosis in a Late-Breaking Oral Presentation at MSToronto2026
Oct 23, 2026 07:00 AM · gurufocus.com
Avis Budget Group Inc (CAR) Shares Fall 4.0% -- What GF Score of 72 Tells Investors
Oct 21, 2026 03:41 PM · gurufocus.com
New Strong Sell Stocks for October 20th
Oct 20, 2026 02:45 AM · zacks.com
Xenetic Biosciences and PeriNess Announce First Patient Dosed in Investigator-Initiated Study at Tel Aviv Sourasky University Medical Center Evaluating Systemic DNase in Combination with CAR T Cells for Large B-Cell Lymphoma
Oct 15, 2026 04:46 AM · accessnewswire.com
Legend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T Therapy
Oct 15, 2026 04:00 AM · globenewswire.com
Lakefront Announces Sale of Preclinical CAR-T Programs to Armed Cell Therapeutics
Oct 14, 2026 12:01 PM · globenewswire.com
Anixa Biosciences' Ovarian Cancer CAR-T Therapy Inventor to Deliver Keynote at Ovarian Cancer Midwest Focus Conference
Oct 13, 2026 04:40 AM · prnewswire.com
Hertz Rebounds 16% From a Record Low; Avis Climbs 5%, Ryder Ticks Up
Oct 06, 2026 10:04 AM · 247wallst.com
Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial
Oct 05, 2026 04:15 AM · prnewswire.com